Package 72189-594-04

{"route": ["ORAL"], "spl_id": "410c1df4-2156-d672-e063-6394a90ab376", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["26a43531-c62a-9e7f-e063-6394a90a8d3f"], "manufacturer_name": ["Direct _Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET in 1 BOTTLE (72189-594-04)", "package_ndc": "72189-594-04", "marketing_start_date": "20241111"}, {"sample": false, "description": "16 TABLET in 1 BOTTLE (72189-594-16)", "package_ndc": "72189-594-16", "marketing_start_date": "20241111"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (72189-594-21)", "package_ndc": "72189-594-21", "marketing_start_date": "20241111"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-594-30)", "package_ndc": "72189-594-30", "marketing_start_date": "20241111"}], "brand_name": "Valacyclovir", "product_id": "72189-594_410c1df4-2156-d672-e063-6394a90ab376", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72189-594", "generic_name": "Valacyclovir", "labeler_name": "Direct _Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20241111", "listing_expiration_date": "20261231"}